BIO-Europe Spring^® 2014 Press Releases

March 14, 2013BIO-Europe Spring^® 2013 in Barcelona hosted over 2,000 executives from the life science sector The seventh annual BIO-Europe Spring^® international partnering conference concluded this week in Barcelona, Spain. The event, held March 11–13, 2013 at the CCIB Convention Centre Barcelona, welcomed more than 2,000 participants representing over 1,200 companies from 50 countries vying for an estimated 2,148 licensing opportunities. Close to 11,000 one-to-one meetings took pl...more ►

February 20, 2013VC Community is gearing up for BIO-Europe Spring^® 2013Investors will be a strong presence at partnering event
The seventh annual BIO-Europe Spring^® international partnering conference will be held at the CCIB Convention Centre Barcelona in Barcelona, Spain, March 11–13, 2013. High attendance by pharma and biotech investors and venture capital firms are expected at the event which will draw more than 2,000 executive-level attendees from over 1,300 companies. "Over recent years, th...more ►

January 24, 2013BIO-Europe Spring^® 2013 in Barcelona to feature C-level program speakersOpening Plenary and Defined Health track reflect the pulse of the industry
The seventh annual BIO-Europe Spring^® international partnering conference will be held in Barcelona, Spain March 11–13, 2013 at the CCIB Convention Centre Barcelona. The event is expected to draw over 2,000 attendees, 75% of whom represent C-level executives/ VPs and directors, from over 1,300 companies. "BIO-Europe Spring is our flagship companion event to BIO-Europe in ...more ►

December 11, 2012BIO-Europe Spring^® 2013 to bring international biopharma leaders to Barcelona for partnering The seventh annual BIO-Europe Spring^® international partnering conference will be held in Barcelona, Spain March 11–13, 2013 at the CCIB Convention Centre Barcelona. The event is expected to draw 2,000 attendees representing C-level executives and key decision makers from over 1,200 companies. "The Catalonia region has the infrastructure to support a dynamic life science ...more ►

18 March 2013 Elegant dysfunction in the push-pull of partnering Everything has changed in partnering on both sides of the table except the necessary tension for negotiating a good deal. Yet if the relations between VCs and pharma executives are strained, they still can't get enough of each other. more ►

18 March 2013 Human data and teaching buyers won big deals in 2012 A mix of novel science and bold selling strategies won the big bio-bucks and stole headlines as top deals over the past year. A few of the winners shared their secrets in this panel session at BIO-Europe Spring^® 2013. more ►

18 March 2013 A view from the West: Trends in biotech venture exits The last year in biotech saw a breakout from prior performance on multiple fronts across stocks, drug approvals, venture returns, and pharma investing. more ►

18 March 2013 Should we fund technology or people in early stage innovation? Is the value in translational research and preclinical programs to be found in the science or the people who are carrying forward a potential breakthrough? Three executives on the front lines of investing offer surprising insights. more ►

18 March 2013 EU austerity puts pharma under “the tyranny of the urgent” Dramatic cost cutting in the five nations hardest hit by austerity measures is having "transmission effects" across the European Union with price cuts, reimbursement review and increasingly tender offers. more ►